What is Wixela Inhub 250/50?
Wixela Inhub 250/50 is a prescription inhaler that combines:
- Fluticasone propionate (an inhaled corticosteroid) and
- Salmeterol (a long-acting beta2-agonist).
The strength “250/50” refers to the amount of fluticasone (250 micrograms) and salmeterol (50 micrograms) delivered per actuation.
What is it used for?
Wixela Inhub 250/50 is used as controller (maintenance) therapy for asthma, helping prevent symptoms and flare-ups in people whose asthma is not controlled on an inhaled steroid alone.
It is also used for asthma patients who need both an anti-inflammatory medicine (fluticasone) and a long-acting bronchodilator (salmeterol).
How is it taken (and how often)?
It’s typically used as a twice-daily inhaler for asthma controller treatment, with the exact dosing schedule set by your clinician. Some patients may be prescribed a specific dose schedule within that twice-daily framework.
Do not use it to treat sudden shortness of breath or an asthma attack—patients generally need a fast-acting rescue inhaler for that.
How does it differ from other Wixela strengths?
Other Wixela strengths use the same two medicines, just in different amounts of fluticasone and salmeterol. If you’re comparing versions (for example, lower or higher fluticasone strengths), the main change is the inhaled steroid dose level; the salmeterol component is tied to the product strength.
Important safety points people ask about
Because it includes salmeterol (a LABA), Wixela carries specific safety considerations for asthma use. Patients are usually instructed to:
- Use it daily as maintenance therapy, not just when symptoms appear.
- Keep using prescribed rescue medication for sudden symptoms.
- Seek medical help if symptoms worsen or rescue inhaler use increases.
Where to confirm the exact product details
Drug naming and strengths can vary by country and packaging. To confirm exactly what “250/50” means on your specific box, check the label section that lists “fluticasone propionate” and “salmeterol” strengths, and the directions for use.
Sources
No sources were provided in your prompt. If you share your country (or a photo/text of the label) or the full wording on your box, I can verify the exact interpretation of “Wixela Inhub 250 50” and typical dosing guidance for that product.